Clinical Trial Site

N. Efkapria-Pavlos Melas 564 03

1 studies enrolling now · 1 studies all time

What they study most

High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension

Studies at this site

• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now